0.84  0.097 (13.09%)		07-30 16:00
Open: 0.7599 High: 0.86 Volume: 311,862		Pre. Close: 0.7428 Low: 0.7492 Market Cap: 13(M)

Short term
Mid term
Targets	6-month :	1.07	1-year :	1.34
Resists	First :	0.92	Second :	1.14
Pivot price	0.75
Supports	First :	0.55	Second :	0.46
MAs	MA(5) :	0.75	MA(20) :	0.8
	MA(100) :	0.72	MA(250) :	2.23
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	36.9	D(3) :	25
RSI	RSI(14): 53.9
52-week	High :	7.19	Low :	0.46

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CALC ] has closed below upper band by 16.0%. Bollinger Bands are 21.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.86 - 0.86	0.86 - 0.87
Low:	0.74 - 0.74	0.74 - 0.75
Close:	0.83 - 0.84	0.84 - 0.85

CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.

Wed, 29 Jul 2026
CalciMedica Inc (CALC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Wed, 29 Jul 2026
A disease causing 300,000 U.S. hospitalizations has no approved therapy - stocktitan.net

Mon, 27 Jul 2026
CalciMedica Inc (CALC) Balance Sheet - TradingKey

Mon, 27 Jul 2026
CalciMedica Inc (CALC) Cash Flow - TradingKey

Sun, 26 Jul 2026
CalciMedica, Inc. Revenue Breakdown – NASDAQ:CALC - TradingView

Fri, 24 Jul 2026
CalciMedica (NASDAQ: CALC) files to register 56M shares from June 2026 PIPE - stocktitan.net

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	16 (M)
Shares Float	2 (M)
Held by Insiders	13.6 (%)
Held by Institutions	23.2 (%)
Shares Short	961 (K)
Shares Short P.Month	276 (K)

EPS	-1.31
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.08
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-81.9 %
Return on Equity (ttm)	-399.6 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.41
Qtrly Earnings Growth	0 %
Operating Cash Flow	-21 (M)
Levered Free Cash Flow	-13 (M)

PE Ratio	-0.65
PEG Ratio	0
Price to Book value	-12
Price to Sales	0
Price to Cash Flow	-0.63

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.